The global enteric disease testing market is estimated at USD 1.8 billion in 2021; it is projected to grow at a CAGR of 6.0% to reach USD 2.4 billion by 2026. The enteric disease testing market is a rapidly growing field, driven by increasing incidence of enteric infections and rising demand for rapid and accurate diagnostic methods. Enteric diseases, also known as intestinal infections, are a common problem worldwide and can cause a wide range of symptoms such as diarrhea, vomiting, and abdominal pain. These symptoms can range from mild to severe, and in some cases can be fatal.
One of the major drivers of the enteric disease testing market is the increasing incidence of enteric infections. According to the World Health Organization (WHO), there are an estimated 1.7 billion cases of diarrhea annually, resulting in around 1.3 million deaths, mostly in children under the age of five. The incidence of enteric infections is higher in developing countries, where access to clean water and adequate sanitation is limited.
Another driver of the enteric disease testing market is the rising demand for rapid and accurate diagnostic methods. Traditional methods of enteric disease diagnosis, such as culture-based methods, can take several days to produce results, which can delay treatment and lead to the spread of the infection. Rapid diagnostic tests (RDTs), such as lateral flow assays and ELISA, can produce results in as little as 15 minutes, allowing for more prompt treatment and reducing the spread of the infection.
The enteric disease testing market is segmented based on the type of test, the type of sample, and the end-user. By test type, the market is divided into culture-based methods, molecular methods, and RDTs. Culture-based methods, such as stool culture, are the most widely used method of enteric disease diagnosis, but are time-consuming and can be less sensitive than other methods. Molecular methods, such as PCR, are highly sensitive and specific but are more expensive and require specialized equipment. RDTs, such as lateral flow assays and ELISA, are simple to use, rapid, and relatively inexpensive, making them a popular choice for point-of-care testing.
By sample type, the market is divided into stool, blood, and other samples. Stool samples are the most commonly used for enteric disease diagnosis, as they can be easily collected and transported to a laboratory for testing. Blood samples are used primarily for the diagnosis of invasive enteric infections, such as typhoid fever and paratyphoid fever.
The end-users of the enteric disease testing market include hospitals, clinics, and diagnostic laboratories. Hospitals and clinics are the largest end-users of enteric disease tests, as they are responsible for the majority of enteric disease diagnosis and treatment. Diagnostic laboratories, both in-house and independent, also play an important role in the enteric disease testing market, as they provide diagnostic services to hospitals and clinics.
In conclusion, the enteric disease testing market is a rapidly growing field, driven by increasing incidence of enteric infections and rising demand for rapid and accurate diagnostic methods. The market is segmented based on the type of test, the type of sample, and the end-user, with RDTs and stool samples being the most popular among the hospitals and clinics. The market is expected to grow in the future due to the increasing incidence of enteric infections, rising demand for rapid diagnostic methods and the growing focus on the development of new and advanced diagnostic methods.
